drugset / Trial / NCT04810507
MAGE of Anagliptin Compared With Sitagliptin With Type 2 Diabetes Mellitus
RandomizedParallel-groupOpen-labelTreatment
Summary
An exploratory study to evaluate the Effect of Improving Glycemic Variability of Anagliptin Compared with Sitagliptin in Patients with Type 2 Diabetes Mellitus
Timeline
- Start
- 2018-11-09
- Primary completion
- 2020-09-02
- Completion
- 2021-01-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anagliptin | Small molecule | 100 mg | — |
| Subject | Sitagliptin | Small molecule | 100 mg | — |